Poorly Differentiated Thyroid Gland Carcinoma
specificA follicular-derived thyroid gland carcinoma that is histologically poorly differentiated and has high-grade features.
17
Centers
12
Active Trials
—
Cancer Funding
Top Centers for Poorly Differentiated Thyroid Gland Carcinoma(17)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 74.1 |
| 2 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 60.9 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 60.9 |
| 4 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 60.9 |
| 5 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 60.9 |
| 6 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 60.9 |
| 7 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 60.9 |
| 8 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 60.9 |
| 9 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 60.9 |
| 10 | Active Research Program | 60.9 |
| 11 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 39.7 |
| 12 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 39.7 |
| 13 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 39.7 |
| 14 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 39.7 |
| 15 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 39.7 |
| 16 | University of Illinois Cancer CenterChicago, IL | 39.7 |
| 17 | Boston University Cancer CenterBoston, MA | 39.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →